Continuous subcutaneous insulin infusion therapy (CSII) influences cardiovascular responses to graded exercise in patients with autonomic diabetic neuropathy of the cardiovascular system (ADNCS).

Source:http://linkedlifedata.com/resource/pubmed/id/3870617

Download in:

View as

General Info

PMID
3870617